Hi Lisa~
You've probably already gotten the info you needed re:access to Tykerb, but I thought I'd share w/you the info I've gathered.
I've been exploring this new
EAP Lapatinib+Capecitibine trial too. I spoke w/a coordinator @ 888-489-5372 & she was very helpful & is sending info in the mail. If you go to the clinicaltrials.gov site & enter "EAP Lapatinib" a good amount of info pops up, including sites in every state.
The Principal Investigator @the site here in Atlanta is the same MD that was the PI on a previous clinical trial I was enrolled in, so was able to get a little more inside scoop.
I was told that the enrollment/pt.accrual schedule is 1 patient per month, but that may be a different @the site that near you.You must have "measureable disease" and
"Progressive disease following treatment with anthracyclines, taxanes and trastuzumab (Herceptin)-(trastuzumab must have been for treatment of advanced or metastatic disease). "
I'm not eligible for the trial for a couple of reasons-no previous anthracycline (like Adriamycin or Doxil) and by some truly,great miracle (see other post!!!), no measureable disease

Hoping your access to Tykerb is not far away...
Keep the Faith!